Curative’s transformation from pandemic testing to employer health insurance gives Wilson-Ciranna an unusual vantage point on growth, risk and operating finance. She explains why the company committed roughly $500 million to its insurance launch and how its zero-deductible, zero-copay model is designed to remove barriers that can discourage people from seeking preventive care or taking needed medications.u…
Wilson-Ciranna also takes listeners inside the economics of the model—from medical loss ratios and provider-network costs to the market feedback that led Curative to expand beyond its original single-plan approach. AI has become another operating lever, helping Curative automate processes and dramatically accelerate provider credentialing.
Her career provides another thread. Experiences at Arthur Andersen, Prolacta Bioscience and Curative progressively widened her responsibilities beyond traditional finance. Today, that operating orientation shapes a simple philosophy: tackle what needs doing, learn what you don’t know, and build for where the business needs to be next.